FindTrial
Sign In

Health Indicators in Type 2 Diabetes: Inflammation Levels and Good Cholesterol

A Study on C-reactive protein and HDL-Cholesterol ration in Type 2 Diabetes Mellitus. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/11/097999
Enrollment
124
Registered
2025-11-24
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H36- Retinal disorders in diseases classified elsewhere

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Dr.Bokula Navya Yadav
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ADULTS AGED 30-75 YEARS DIAGNOSED WITH TYPE 2 DIABETES MELLITUS AS PER ADA CRITERIA.

Exclusion criteria

Exclusion criteria: TYPE 1 DIABETES MELLITUS. SYSTEMIC INFECTIONS- PNEUMONIA, SEPTICEMIA, CHRONIC INFLAMMATORY CONDITIONS LIKE -RA, SLE. USE OF ANTI-INFLAMMATORY ( CORTICOSTEROIDS) OR LIPID LOWERING DRUGS( STATINS) IN THE LAST 3 MONTHS. CHRONIC LIVER DISEASE, CHRONIC KIDNEY DISEASE. RENAL/LIVER MALIGNANCIES.

Design outcomes

Primary

MeasureTime frame
Higher CRP/HDL-C ratios in DR patients compared to non-DRTimepoint: At the time of visit to the hospital - day 1.—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactDrBokula Navya Yadav

Alluri Sitaramaraju Academy of Medical Sciences

vivekanandu@gmail.com9550659635

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026